SE452250C - Sätt att framställa ett koncentrat av protrombinkomplex - Google Patents
Sätt att framställa ett koncentrat av protrombinkomplexInfo
- Publication number
- SE452250C SE452250C SE8009157A SE8009157A SE452250C SE 452250 C SE452250 C SE 452250C SE 8009157 A SE8009157 A SE 8009157A SE 8009157 A SE8009157 A SE 8009157A SE 452250 C SE452250 C SE 452250C
- Authority
- SE
- Sweden
- Prior art keywords
- prothrombin complex
- heparin
- source
- iii
- concentrate
- Prior art date
Links
- 102100027378 Prothrombin Human genes 0.000 title claims description 24
- 108010094028 Prothrombin Proteins 0.000 title claims description 24
- 229940039716 prothrombin Drugs 0.000 title claims description 24
- 239000012141 concentrate Substances 0.000 title claims description 12
- 238000000034 method Methods 0.000 title claims description 11
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 16
- 229960002897 heparin Drugs 0.000 claims description 16
- 229920000669 heparin Polymers 0.000 claims description 16
- 238000010828 elution Methods 0.000 claims description 9
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 7
- 238000001179 sorption measurement Methods 0.000 claims description 7
- 102000004411 Antithrombin III Human genes 0.000 claims description 5
- 108090000935 Antithrombin III Proteins 0.000 claims description 5
- 229960005348 antithrombin iii Drugs 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 102100027827 Complexin-3 Human genes 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 102100022641 Coagulation factor IX Human genes 0.000 description 2
- 108010076282 Factor IX Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 229960004222 factor ix Drugs 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229940038773 trisodium citrate Drugs 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 108010032608 Cohn fraction IV Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 208000015294 blood coagulation disease Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000009852 coagulant defect Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7911272A FR2472390A1 (fr) | 1979-05-04 | 1979-05-04 | Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus |
PCT/FR1980/000069 WO1980002426A1 (fr) | 1979-05-04 | 1980-05-05 | Concentres de complexe prothrombinique, preparation et application |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8009157L SE8009157L (sv) | 1980-12-29 |
SE452250B SE452250B (sv) | 1987-11-23 |
SE452250C true SE452250C (sv) | 1998-04-06 |
Family
ID=9225039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8009157A SE452250C (sv) | 1979-05-04 | 1980-12-29 | Sätt att framställa ett koncentrat av protrombinkomplex |
Country Status (18)
Country | Link |
---|---|
US (1) | US4465623A (de) |
JP (1) | JPH0424360B2 (de) |
AR (1) | AR227021A1 (de) |
AT (1) | ATA903980A (de) |
BE (1) | BE883096A (de) |
CA (1) | CA1157375A (de) |
CH (1) | CH654329A5 (de) |
DE (1) | DE3043409C3 (de) |
DK (1) | DK157169C (de) |
ES (1) | ES491042A0 (de) |
FR (1) | FR2472390A1 (de) |
GB (1) | GB2061287B (de) |
IT (1) | IT1131109B (de) |
MX (1) | MX5960E (de) |
NL (1) | NL8020152A (de) |
NO (1) | NO155477C (de) |
SE (1) | SE452250C (de) |
WO (1) | WO1980002426A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663164A (en) * | 1980-01-28 | 1987-05-05 | Baxter Travenol Laboratories, Inc. | Aqueous compositions for treating blood clotting factor inhibitors |
WO1981002105A1 (en) * | 1980-01-28 | 1981-08-06 | Baxter Travenol Lab | Therapeutic compositions & methods for manufacture and use |
AT379310B (de) * | 1983-05-20 | 1985-12-27 | Immuno Ag | Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates |
US4786726A (en) * | 1986-01-06 | 1988-11-22 | Blood Systems, Inc. | Factor IX therapeutic blood product, means and methods of preparing same |
DE3622642A1 (de) * | 1986-07-05 | 1988-01-14 | Behringwerke Ag | Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung |
DE3625090A1 (de) * | 1986-07-24 | 1988-01-28 | Behringwerke Ag | Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung |
DE3727610A1 (de) | 1987-08-19 | 1989-03-02 | Behringwerke Ag | Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung |
US6541275B1 (en) | 1988-02-03 | 2003-04-01 | Dade Behring Inc. | Immunoassay for F1.2 prothrombin fragment |
JPH0219400A (ja) * | 1988-07-07 | 1990-01-23 | Green Cross Corp:The | トロンビンまたはプロトロンビンの製造方法 |
US5589516A (en) * | 1993-04-05 | 1996-12-31 | The Green Cross Corporation | Liquid preparation of antithrombin-III and stabilizing method therefor |
US7045585B2 (en) * | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
US6562781B1 (en) | 1995-11-30 | 2003-05-13 | Hamilton Civic Hospitals Research Development Inc. | Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
US6491965B1 (en) * | 1995-11-30 | 2002-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
US20080306610A1 (en) * | 2007-06-07 | 2008-12-11 | Zimmer Orthobiologics, Inc. | Tissue processing for nonimmunogenic implants |
US8435305B2 (en) | 2010-08-31 | 2013-05-07 | Zimmer, Inc. | Osteochondral graft delivery device and uses thereof |
USD850006S1 (en) | 2017-11-27 | 2019-05-28 | Mary Kay Inc. | Cosmetic compact |
USD843660S1 (en) | 2017-11-27 | 2019-03-19 | Mary Kay Inc. | Cosmetic compact |
USD863685S1 (en) | 2017-11-27 | 2019-10-15 | Mary Kay Inc. | Cosmetic compact |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2867567A (en) * | 1955-01-21 | 1959-01-06 | Nat Res Dev | Process of preparing anti-haemophilic globulin |
US3560475A (en) * | 1969-06-19 | 1971-02-02 | Baxter Laboratories Inc | Prothrombin complex prepared by precipitation with polyethylene glycol |
JPS5314604B2 (de) * | 1972-12-20 | 1978-05-18 | ||
US4087415A (en) * | 1976-06-09 | 1978-05-02 | William L. Wilson | Antithrombin III |
US4081432A (en) * | 1977-07-25 | 1978-03-28 | Monsanto Company | Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers |
JPS6040859B2 (ja) * | 1977-07-27 | 1985-09-12 | 喜温 三浦 | 抗血栓性人工医療材料 |
AT359646B (de) * | 1979-04-19 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen |
DE3101752A1 (de) * | 1981-01-21 | 1982-08-26 | Behringwerke Ag, 3550 Marburg | "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen" |
-
1979
- 1979-05-04 FR FR7911272A patent/FR2472390A1/fr active Granted
-
1980
- 1980-04-30 ES ES491042A patent/ES491042A0/es active Granted
- 1980-05-02 BE BE0/200456A patent/BE883096A/fr not_active IP Right Cessation
- 1980-05-02 CA CA000351182A patent/CA1157375A/fr not_active Expired
- 1980-05-02 IT IT21723/80A patent/IT1131109B/it active
- 1980-05-05 WO PCT/FR1980/000069 patent/WO1980002426A1/fr active Application Filing
- 1980-05-05 AR AR280901A patent/AR227021A1/es active
- 1980-05-05 CH CH98/81A patent/CH654329A5/fr not_active IP Right Cessation
- 1980-05-05 DE DE3043409T patent/DE3043409C3/de not_active Expired - Fee Related
- 1980-05-05 NL NL8020152A patent/NL8020152A/nl active Search and Examination
- 1980-05-05 JP JP55500927A patent/JPH0424360B2/ja not_active Expired
- 1980-05-05 AT AT0903980A patent/ATA903980A/de unknown
- 1980-05-05 GB GB8040646A patent/GB2061287B/en not_active Expired
- 1980-05-06 MX MX808799U patent/MX5960E/es unknown
- 1980-12-29 SE SE8009157A patent/SE452250C/sv not_active IP Right Cessation
-
1981
- 1981-01-02 DK DK001281A patent/DK157169C/da not_active IP Right Cessation
- 1981-01-02 NO NO81810009A patent/NO155477C/no unknown
-
1983
- 1983-03-17 US US06/476,126 patent/US4465623A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NO155477B (no) | 1986-12-29 |
ATA903980A (de) | 1982-05-15 |
IT1131109B (it) | 1986-06-18 |
DE3043409C3 (de) | 1993-12-23 |
DE3043409C2 (de) | 1993-12-23 |
DK1281A (da) | 1981-01-02 |
WO1980002426A1 (fr) | 1980-11-13 |
FR2472390B1 (de) | 1983-07-08 |
JPS56500569A (de) | 1981-04-30 |
GB2061287A (en) | 1981-05-13 |
SE452250B (sv) | 1987-11-23 |
US4465623A (en) | 1984-08-14 |
NO810009L (no) | 1981-01-02 |
CA1157375A (fr) | 1983-11-22 |
MX5960E (es) | 1984-09-06 |
IT8021723A0 (it) | 1980-05-02 |
GB2061287B (en) | 1983-09-14 |
NL8020152A (nl) | 1981-02-27 |
BE883096A (fr) | 1980-11-03 |
FR2472390A1 (fr) | 1981-07-03 |
ES8100763A1 (es) | 1980-12-01 |
DK157169B (da) | 1989-11-20 |
DK157169C (da) | 1990-04-23 |
DE3043409T1 (de) | 1982-02-18 |
JPH0424360B2 (de) | 1992-04-24 |
CH654329A5 (fr) | 1986-02-14 |
NO155477C (no) | 1987-04-08 |
SE8009157L (sv) | 1980-12-29 |
AR227021A1 (es) | 1982-09-15 |
ES491042A0 (es) | 1980-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE452250C (sv) | Sätt att framställa ett koncentrat av protrombinkomplex | |
AT407115B (de) | Verfahren zur herstellung eines konzentrates von standardisiertem, menschlichem von willebrand-faktor | |
JP3701028B2 (ja) | 高純度フォンビルブラント因子の入手方法 | |
US5099003A (en) | Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii | |
CA2009946C (en) | Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof | |
JP2644946B2 (ja) | IgG− モノクロナール抗体の精製方法及びその使用方法 | |
SE459784B (sv) | Stabiliserad torr antitrombinberedning | |
EP0314095A1 (de) | Plasma- und Rekombinationsproteinformulierungen in einem Milieu hoher Ionenstärke | |
JPH01207239A (ja) | 高純度のヒト因子ix濃縮物および他の血漿蛋白質およびそれらの治療学的使用 | |
HU182554B (en) | Process for producing preparation of serum protein for intravenous application | |
AU2003244850B2 (en) | Processes for the preparation of fibrinogen | |
EP0239565B1 (de) | Verfahren zur Trennung von Proteinen | |
AU744919B2 (en) | Method for purifying factor VIII/VWF complex by cation-exchange chromatography | |
NO324659B1 (no) | Utvinning av von Willebrand-faktor ved kationebytterkromatografi samt preparat inneholdende slik faktor og anvendelse derav. | |
Surgenor et al. | A system for the separation of the protein components of human plasma. II. The components of the clotting process. | |
JPS59222420A (ja) | 第8因子含有製剤の製造法 | |
JPH04502106A (ja) | 第x3因子の精製 | |
CN105481976B (zh) | 一种制备人凝血因子viii的离子交换层析用洗涤缓冲液及其用途 | |
EP0245875A2 (de) | Verfahren zur Reinigung von Faktor-VIII | |
EP0052874A1 (de) | Verfahren zum Erzeugen der Vorgerinnungsaktivität des Faktors VIII | |
JPS59167519A (ja) | 不活化トロンビンゲルにより血漿タンパク質混合液からフイブリノ−ゲンを除去する方法 | |
JPH06505243A (ja) | 内皮細胞の増殖に対する新規抑制因子 | |
JPH02247199A (ja) | ヒト血液凝固第x3因子の製造法 | |
JPH06311883A (ja) | プラスミノゲンの製造方法 | |
SI9012105A (sl) | Postopek za izoliranje biološko aktivnih spoji |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8009157-2 Format of ref document f/p: F |